Search results

• 2022

  Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes

  Zhou, J., Liu, X., Chou, O. H-I., Li, L., Lee, S., Wong, W. T., Zhang, Q., Chang, C., Liu, T., Tse, G., Jing, F. & Cheung, B. M. Y., 6 Sept 2022, (E-pub ahead of print) In: Rheumatology.

  Research output: Contribution to journal › Article › peer-review

  • Incidence Rate 100%
  • Interquartile Range 66%
  • Cohort Study 62%
  • Regression Model 33%
  • Median 33%
  16 Citations (Scopus)